Multiple Myeloma studies for 2018 Data from Daratumumab with carfilzomib, lenalidomide etc

Robert Z. Orlowski, MD, PhD, from The University of Texas MD Anderson Cancer Center discusses multiple myeloma studies for 2018 data from daratumumab with carfilzomib, lenalidomide etc at the 2017 American Society of Hematology.